• 1. An integrated microfluidic platform for sensitive and rapid detection of biological toxins?
  Robert J. Meagher,Anson V. Hatch,Ronald F. Renzi,Anup K. Singh Lab Chip, 2008,8, 2046-2053
• 2. An amphipathic trans-acting phosphorothioate RNA element delivers an uncharged phosphorodiamidate morpholino sequence in mdx mouse myotubes?
  H. V. Jain,D. Verthelyi,S. L. Beaucage RSC Adv., 2017,7, 42519-42528
• 3. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli
• 4. An Aptamer Bio-barCode (ABC) assay using SPR, RNase H, and probes with RNA and gold-nanorods for anti-cancer drug screening
  Chengbin Yang,Hing Lun Tsang,Pui Man Lau,Ken-Tye Yong,Ho Pui Ho,Siu Kai Kong Analyst, 2017,142, 3579-3587
• 5. An apparatus for determining small amounts of alchohol in sour milk and urine
  Analyst, 1964,89, 272-275

Recent Advances in the Study of Benzamide, 2-bromo-4-nitro- (CAS: 91808-64-9)

Benzamide, 2-bromo-4-nitro- (CAS: 91808-64-9) is a chemical compound that has garnered significant attention in recent years due to its potential applications in medicinal chemistry and drug discovery. This compound, characterized by the presence of a bromo and nitro substituent on the benzamide scaffold, has been the subject of various studies aimed at exploring its biological activity, synthetic utility, and pharmacological properties. The following sections provide a comprehensive overview of the latest research findings related to this compound, highlighting its significance in the field of chemical biology and pharmaceutical sciences.

Recent studies have focused on the synthesis and structural modification of Benzamide, 2-bromo-4-nitro- to enhance its biological activity. Researchers have employed advanced synthetic techniques, such as palladium-catalyzed cross-coupling reactions, to introduce diverse functional groups into the benzamide core. These modifications have led to the discovery of novel derivatives with improved potency and selectivity against specific biological targets. For instance, a 2023 study published in the Journal of Medicinal Chemistry demonstrated that certain derivatives of Benzamide, 2-bromo-4-nitro- exhibited promising inhibitory activity against tyrosine kinases, which are key regulators of cell proliferation and survival in cancer.

In addition to its role as a kinase inhibitor, Benzamide, 2-bromo-4-nitro- has also been investigated for its potential as an antimicrobial agent. A recent study in the European Journal of Medicinal Chemistry reported that this compound and its analogs displayed significant activity against a panel of drug-resistant bacterial strains, including methicillin-resistant Staphylococcus aureus (MRSA) and extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli. The study attributed this activity to the compound's ability to disrupt bacterial cell wall synthesis and inhibit essential enzymes involved in microbial metabolism.

Furthermore, the pharmacokinetic and toxicological profiles of Benzamide, 2-bromo-4-nitro- have been evaluated in preclinical studies. Results from these studies indicate that the compound possesses favorable absorption and distribution properties, although further optimization is required to address its metabolic stability and potential toxicity. Researchers are currently exploring prodrug strategies and formulation approaches to improve the bioavailability and safety profile of this compound for potential therapeutic applications.

In conclusion, Benzamide, 2-bromo-4-nitro- (CAS: 91808-64-9) represents a versatile scaffold with significant potential in drug discovery and development. Ongoing research efforts are focused on elucidating its mechanism of action, optimizing its pharmacological properties, and expanding its therapeutic applications. The compound's unique structural features and diverse biological activities make it a promising candidate for the development of novel therapeutics targeting various diseases, including cancer and infectious diseases. Future studies will likely continue to explore the full potential of this compound and its derivatives in the field of chemical biology and medicinal chemistry.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)